 |
市場調査レポート
商品コード
1269440
ペニシリンGアシラーゼ市場- 世界の産業分析、規模、シェア、成長、動向、および予測、2022-2031年Penicillin G Acylase Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
価格
| ペニシリンGアシラーゼ市場- 世界の産業分析、規模、シェア、成長、動向、および予測、2022-2031年 |
|
出版日: 2023年03月03日
発行: Transparency Market Research
ページ情報: 英文 157 Pages
納期: 2～10営業日
|
- 全表示
- 概要
- 図表
- 目次
概要
ペニシリンGアシラーゼ市場- 調査範囲：
本レポートでは、2022年を基準年、2031年を予測年として、2017年から2031年にかけての世界のペニシリンGアシラーゼ市場の収益を提供します。また、2022年から2031年までの世界のペニシリンGアシラーゼ市場のCAGRを掲載しています。
本レポートは、広範な調査を経て作成されました。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施し、調査作業の大部分を行っています。2次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書を参照し、ペニシリンGアシラーゼ市場を把握しました。
本レポートは、世界のペニシリンGアシラーゼ市場の競合情勢を掘り下げています。世界のペニシリンGアシラーゼ市場で活動する主要企業が特定され、それぞれの企業が様々な属性の観点からプロファイリングされています。企業概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界のペニシリンGアシラーゼ市場のプレイヤーの属性です。
目次
第1章 序文
- 市場の定義と範囲
- 市場セグメンテーション
- 主な調査目的
- 調査ハイライト
第2章 前提条件と調査手法
第3章 エグゼクティブサマリー：世界市場
第4章 市場の概要
- イントロダクション
- セグメントの定義
- 概要
- 市場力学
- 促進要因
- 抑制要因
- 機会
- 世界市場の分析と予測、2017-2031年
- 市場収益予測
第5章 主な洞察
- プリフォームとイモビライザーフォーム概要
- 地域別/世界別の規制シナリオ
- COVID-19パンデミックの業界への影響（バリューチェーンと短期/中期/長期的な影響）
第6章 世界市場の分析と予測：ソース別
- イントロダクションと定義
- 主な発見と発展
- 市場価値予測：供給源別、2017-2031年
- 大腸菌
- バチルス・メガテリウム（Bacillus Megaterium）
- その他
- 市場魅力分析：供給源別
第7章 世界市場分析・予測：アプリケーション別
- イントロダクション＆定義
- 主な調査結果・発展状況
- 市場価値予測：用途別、2017年～2031年
- 半合成ペニシリンの生産量
- 半合成セファロスポリンの生産量
- その他
- 市場魅力分析：用途別
第8章 世界市場分析・予測：エンドユーザー別
- イントロダクション＆定義
- 主な調査結果・発展例
- 市場規模予測：エンドユーザー別、2017-2031年
- 製薬会社
- 学術・研究機関
- その他
- 市場魅力分析：エンドユーザー別
第9章 世界市場分析・予測：地域別
- 主な調査結果
- 市場価値予測：地域別
- 北米
- 欧州
- アジア太平洋
- ラテンアメリカ
- 中東・アフリカ地域
- 市場魅力分析：地域別
第10章 北米市場の分析と予測
- イントロダクション
- 主な調査結果
- 市場価値予測：供給源別、2017-2031年
- 大腸菌
- バチルス・メガテリウム（Bacillus Megaterium）
- その他
- 市場価値予測：用途別、2017-2031年
- 半合成ペニシリンの生産量
- 半合成セファロスポリンの生産量
- その他
- 市場価値予測：エンドユーザー別、2017-2031年
- 製薬会社
- 学術・研究機関
- その他
- 市場価値予測：国別、2017-2031年
- 米国
- カナダ
- 市場の魅力分析
- ソース別
- 用途別
- エンドユーザー別
- 国別
第11章 欧州市場の分析と予測
- イントロダクション
- 主要な調査結果
- 市場価値予測：供給源別、2017-2031年
- 大腸菌
- バチルス・メガテリウム（Bacillus Megaterium）
- その他
- 市場価値予測：用途別、2017-2031年
- 半合成ペニシリンの生産量
- 半合成セファロスポリンの生産量
- その他
- 市場価値予測：エンドユーザー別、2017-2031年
- 製薬会社
- 学術・研究機関
- その他
- 市場価値予測：国・小地域別、2017-2031年
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- その他欧州
- 市場の魅力分析
- ソース別
- 用途別
- エンドユーザー別
- 国別／サブリージョン別
第12章 アジア太平洋地域の市場分析と予測
- イントロダクション
- 主要な調査結果
- 市場価値予測：供給源別、2017年～2031年
- 大腸菌
- バチルス・メガテリウム（Bacillus Megaterium）
- その他
- 市場価値予測：用途別、2017-2031年
- 半合成ペニシリンの生産量
- 半合成セファロスポリンの生産量
- その他
- 市場価値予測：エンドユーザー別、2017-2031年
- 製薬会社
- 学術・研究機関
- その他
- 市場価値予測：国・小地域別、2017-2031年
- 中国
- 日本
- インド
- オーストラリア・ニュージーランド
- その他アジア太平洋地域
- 市場の魅力分析
- ソース別
- 用途別
- エンドユーザー別
- 国別／サブリージョン別
第13章 ラテンアメリカの市場分析・予測
- イントロダクション
- 主要な調査結果
- 市場価値予測：供給源別、2017年～2031年
- 大腸菌
- バチルス・メガテリウム（Bacillus Megaterium）
- その他
- 市場価値予測：用途別、2017-2031年
- 半合成ペニシリンの生産量
- 半合成セファロスポリンの生産量
- その他
- 市場価値予測：エンドユーザー別、2017-2031年
- 製薬会社
- 学術・研究機関
- その他
- 市場価値予測：国・小地域別、2017-2031年
- ブラジル
- メキシコ
- その他ラテンアメリカ地域
- 市場魅力分析
- ソース別
- 用途別
- エンドユーザー別
- 国別／サブリージョン別
第14章 中東・アフリカ市場の分析・予測
- イントロダクション
- 主な調査結果
- 市場価値予測：供給源別、2017年～2031年
- 大腸菌
- バチルス・メガテリウム（Bacillus Megaterium）
- その他
- 市場価値予測：用途別、2017-2031年
- 半合成ペニシリンの生産量
- 半合成セファロスポリンの生産量
- その他
- 市場価値予測：エンドユーザー別、2017-2031年
- 製薬会社
- 学術・研究機関
- その他
- 市場価値予測：国・小地域別、2017-2031年
- GCC諸国
- 南アフリカ
- その他中東・アフリカ
- 市場の魅力分析
- ソース別
- 用途別
- エンドユーザー別
- 国別／サブリージョン別
第15章 競合情勢
- 市場競争者-競争マトリックス（企業の階層別、規模別）
- 企業プロファイル
- Merck KGaA（Sigma Aldrich）
- Fermenta Biotech Ltd.
- Biosynth
- Amicogen
- Creative Enzymes
- Crawford Wisdom International
- MuseChem Chemicals
図表
List of Tables
- Table 01: Global Penicillin G Acylases Market Value (US$ Mn) Forecast, by Source, 2017-2031
- Table 02: Global Penicillin G Acylases Market Value (US$ Mn) Forecast, by Application, 2017-2031
- Table 03: Global Penicillin G Acylases Market Value (US$ Mn) Forecast, by End-user, 2017-2031
- Table 04: Global Penicillin G Acylases Market Value (US$ Mn) Forecast, by Region, 2017-2031
- Table 05: North America Penicillin G Acylase Market Value (US$ Mn) Forecast, by Source, 2017-2031
- Table 06: North America Penicillin G Acylase Market Value (US$ Mn) Forecast, by Application, 2017-2031
- Table 07: North America Penicillin G Acylase Market Value (US$ Mn) Forecast, by End-user, 2017-2031
- Table 08: North America Penicillin G Acylase Market Value (US$ Mn) Forecast, by Country, 2017-2031
- Table 09: Europe Penicillin G Acylase Market Value (US$ Mn) Forecast, by Source, 2017-2031
- Table 10: Europe Penicillin G Acylase Market Value (US$ Mn) Forecast, by Application, 2017-2031
- Table 11: Europe Penicillin G Acylase Market Value (US$ Mn) Forecast, by End-user, 2017-2031
- Table 12: Europe Penicillin G Acylase Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031
- Table 13: Asia Pacific Penicillin G Acylase Market Value (US$ Mn) Forecast, by Source, 2017-2031
- Table 14: Asia Pacific Penicillin G Acylase Market Value (US$ Mn) Forecast, by Application, 2017-2031
- Table 15: Asia Pacific Penicillin G Acylase Market Value (US$ Mn) Forecast, by End-user, 2017-2031
- Table 16: Asia Pacific Penicillin G Acylase Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
- Table 17: Latin America Penicillin G Acylase Market Value (US$ Mn) Forecast, by Source, 2017-2031
- Table 18: Latin America Penicillin G Acylase Market Value (US$ Mn) Forecast, by Application, 2017-2031
- Table 19: Latin America Penicillin G Acylase Market Value (US$ Mn) Forecast, by End-user, 2017-2031
- Table 20: Latin America Penicillin G Acylase Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
- Table 21: Middle East & Africa Penicillin G Acylase Market Value (US$ Mn) Forecast, by Source, 2017-2031
- Table 22: Middle East & Africa Penicillin G Acylase Market Value (US$ Mn) Forecast, by Application, 2017-2031
- Table 23: Middle East & Africa Penicillin G Acylase Market Value (US$ Mn) Forecast, by End-user, 2017-2031
- Table 24: Middle East & Africa Penicillin G Acylase Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
List of Figures
- Figure 01: Global Penicillin G Acylases Market Value (US$ Mn) Forecast, 2017-2031
- Figure 02: Global Penicillin G Acylases Market Value Share, by Source, 2022
- Figure 03: Global Penicillin G Acylases Market Value Share, by Application, 2022
- Figure 04: Global Penicillin G Acylases Market Value Share, by End-user, 2022
- Figure 05: Global Penicillin G Acylases Market Value Share Analysis, by Source, 2022 and 2031
- Figure 06: Global Penicillin G Acylases Market Attractiveness Analysis, by Source, 2023-2031
- Figure 07: Global Penicillin G Acylases Market Value (US$ Mn), by E. coli, 2017-2031
- Figure 08: Global Penicillin G Acylases Market Value (US$ Mn), by Bacillus Megaterium, 2017-2031
- Figure 09: Global Penicillin G Acylases Market Value (US$ Mn), by Others, 2017-2031
- Figure 10: Global Penicillin G Acylases Market Value Share Analysis, by Application, 2022 and 2031
- Figure 11: Global Penicillin G Acylases Market Attractiveness Analysis, by Application, 2022-2031
- Figure 12: Global Penicillin G Acylases Market Revenue (US$ Mn), by Production of Semisynthetic Penicillin, 2017-2031
- Figure 13: Global Penicillin G Acylases Market Revenue (US$ Mn), by Production of Semisynthetic Cephalosporin, 2017-2031
- Figure 14: Global Penicillin G Acylases Market Revenue (US$ Mn), by Others, 2017-2031
- Figure 15: Global Penicillin G Acylases Market Value Share Analysis, by End-user, 2022 and 2031
- Figure 16: Global Penicillin G Acylases Market Attractiveness Analysis, by End-user, 2023-2031
- Figure 17: Global Penicillin G Acylases Market Revenue (US$ Mn), by Pharmaceutical Companies, 2017-2031
- Figure 18: Global Penicillin G Acylases Market Revenue (US$ Mn), by Academic & Research Institutes, 2017-2031
- Figure 19: Global Penicillin G Acylases Market Revenue (US$ Mn), by Others, 2017-2031
- Figure 20: Global Penicillin G Acylases Market Value Share Analysis, by Region, 2022 and 2031
- Figure 21: Global Penicillin G Acylases Market Attractiveness Analysis, by Region, 2023-2031
- Figure 22: North America Penicillin G Acylase Market Value (US$ Mn) Forecast, 2017-2031
- Figure 23: North America Penicillin G Acylase Market Value Share Analysis, by Source, 2022 and 2031
- Figure 24: North America Penicillin G Acylase Market Attractiveness Analysis, by Source, 2023-2031
- Figure 25: North America Penicillin G Acylase Market Value Share Analysis, by Application, 2022 and 2031
- Figure 26: North America Penicillin G Acylase Market Attractiveness Analysis, by Application, 2023-2031
- Figure 27: North America Penicillin G Acylase Market Value Share Analysis, by End-user, 2022 and 2031
- Figure 28: North America Penicillin G Acylase Market Attractiveness Analysis, by End-user, 2023-2031
- Figure 29: North America Penicillin G Acylase Market Value Share Analysis, by Country, 2022 and 2031
- Figure 30: North America Penicillin G Acylase Market Attractiveness Analysis, by Country, 2023-2031
- Figure 31: Europe Penicillin G Acylase Market Value (US$ Mn) Forecast, 2017-2031
- Figure 32: Europe Penicillin G Acylase Market Value Share Analysis, by Source, 2022 and 2031
- Figure 33: Europe Penicillin G Acylase Market Attractiveness Analysis, by Source, 2023-2031
- Figure 34: Europe Penicillin G Acylase Market Value Share Analysis, by Application, 2022 and 2031
- Figure 35: Europe Penicillin G Acylase Market Attractiveness Analysis, by Application, 2023-2031
- Figure 36: Europe Penicillin G Acylase Market Value Share Analysis, by End-user, 2022 and 2031
- Figure 37: Europe Penicillin G Acylase Market Attractiveness Analysis, by End-user, 2023-2031
- Figure 38: Europe Penicillin G Acylase Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
- Figure 39: Europe Penicillin G Acylase Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
- Figure 40: Asia Pacific Penicillin G Acylase Market Value (US$ Mn) Forecast, 2017-2031
- Figure 41: Asia Pacific Penicillin G Acylase Market Value Share Analysis, by Source, 2022 and 2031
- Figure 42: Asia Pacific Penicillin G Acylase Market Attractiveness Analysis, by Source, 2023-2031
- Figure 43: Asia Pacific Penicillin G Acylase Market Value Share Analysis, by Application, 2022 and 2031
- Figure 44: Asia Pacific Penicillin G Acylase Market Attractiveness Analysis, by Application, 2023-2031
- Figure 45: Asia Pacific Penicillin G Acylase Market Value Share Analysis, by End-user, 2022 and 2031
- Figure 46: Asia Pacific Penicillin G Acylase Market Attractiveness Analysis, by End-user, 2023-2031
- Figure 47: Asia Pacific Penicillin G Acylase Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
- Figure 48: Asia Pacific Penicillin G Acylase Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
- Figure 49: Latin America Penicillin G Acylase Market Value (US$ Mn) Forecast, 2017-2031
- Figure 50: Latin America Penicillin G Acylase Market Value Share Analysis, by Source, 2022 and 2031
- Figure 51: Latin America Penicillin G Acylase Market Attractiveness Analysis, by Source, 2023-2031
- Figure 52: Latin America Penicillin G Acylase Market Value Share Analysis, by Application, 2022 and 2031
- Figure 53: Latin America Penicillin G Acylase Market Attractiveness Analysis, by Application, 2023-2031
- Figure 54: Latin America Penicillin G Acylase Market Value Share Analysis, by End-user, 2022 and 2031
- Figure 55: Latin America Penicillin G Acylase Market Attractiveness Analysis, by End-user, 2023-2031
- Figure 56: Latin America Penicillin G Acylase Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
- Figure 57: Latin America Penicillin G Acylase Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
- Figure 58: Middle East & Africa Penicillin G Acylase Market Value (US$ Mn) Forecast, 2017-2031
- Figure 59: Middle East & Africa Penicillin G Acylase Market Value Share Analysis, by Source, 2022 and 2031
- Figure 60: Middle East & Africa Penicillin G Acylase Market Attractiveness Analysis, by Source, 2023-2031
- Figure 61: Middle East & Africa Penicillin G Acylase Market Value Share Analysis, by Application, 2022 and 2031
- Figure 62: Middle East & Africa Penicillin G Acylase Market Attractiveness Analysis, by Application, 2023-2031
- Figure 63: Middle East & Africa Penicillin G Acylase Market Value Share Analysis, by End-user, 2022 and 2031
- Figure 64: Middle East & Africa Penicillin G Acylase Market Attractiveness Analysis, by End-user, 2023-2031
- Figure 65: Middle East & Africa Penicillin G Acylase Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
- Figure 66: Middle East & Africa Penicillin G Acylase Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
目次
Product Code: TMRGL69416
Penicillin G Acylase Market - Scope of Report:
TMR's report on the global penicillin G acylase market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global penicillin G acylase market for the period 2017-2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global penicillin G acylase market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the penicillin G acylase market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global penicillin G acylase market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global penicillin G acylase market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global penicillin G acylase market.
The report delves into the competitive landscape of the global penicillin G acylase market. Key players operating in the global penicillin G acylase market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global penicillin G acylase market profiled in this report.
Key Questions Answered in Global Penicillin G Acylase Market Report:
- What is the sales/revenue generated by penicillin G acylase across all regions during the forecast period?
- What are the opportunities in the global penicillin G acylase market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2031?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Penicillin G Acylase Market - Research Objectives and Research Approach:
The comprehensive report on the global penicillin G acylase market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global penicillin G acylase market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global penicillin G acylase market.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Penicillin G Acylase Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Segment Definition
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Penicillin G Acylase Market Analysis and Forecast, 2017-2031
- 4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
- 5.1. Penicillin G Acylase Preform and Immobilize form: An Overview
- 5.2. Regulatory Scenario by Region/globally
- 5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Penicillin G Acylase Market Analysis and Forecast, By Source
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Source, 2017-2031
- 6.3.1. E. coli
- 6.3.2. Bacillus Megaterium
- 6.3.3. Others
- 6.4. Market Attractiveness Analysis, By Source
7. Global Penicillin G Acylase Market Analysis and Forecast, By Application
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by Application, 2017-2031
- 7.3.1. Production of Semisynthetic Penicillin
- 7.3.2. Production of Semisynthetic Cephalosporin
- 7.3.3. Others
- 7.4. Market Attractiveness Analysis, By Application
8. Global Penicillin G Acylase Market Analysis and Forecast, By End-user
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast, by End-user, 2017-2031
- 8.3.1. Pharmaceutical Companies
- 8.3.2. Academic & Research Institutes
- 8.3.3. Others
- 8.4. Market Attractiveness Analysis, By End-user
9. Global Penicillin G Acylase Market Analysis and Forecast, By Region
- 9.1. Key Findings
- 9.2. Market Value Forecast, by Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
- 9.3. Market Attractiveness Analysis, By Region
10. North America Penicillin G Acylase Market Analysis and Forecast
- 10.1. Introduction
- 10.1.1. Key Findings
- 10.2. Market Value Forecast, by Source, 2017-2031
- 10.2.1. E. coli
- 10.2.2. Bacillus Megaterium
- 10.2.3. Others
- 10.3. Market Value Forecast, by Application, 2017-2031
- 10.3.1. Production of Semisynthetic Penicillin
- 10.3.2. Production of Semisynthetic Cephalosporin
- 10.3.3. Others
- 10.4. Market Value Forecast, by End-user, 2017-2031
- 10.4.1. Pharmaceutical Companies
- 10.4.2. Academic & Research Institutes
- 10.4.3. Others
- 10.5. Market Value Forecast, by Country, 2017-2031
- 10.5.1. U.S.
- 10.5.2. Canada
- 10.6. Market Attractiveness Analysis
- 10.6.1. By Source
- 10.6.2. By Application
- 10.6.3. By End-user
- 10.6.4. By Country
11. Europe Penicillin G Acylase Market Analysis and Forecast
- 11.1. Introduction
- 11.1.1. Key Findings
- 11.2. Market Value Forecast, by Source, 2017-2031
- 11.2.1. E. coli
- 11.2.2. Bacillus Megaterium
- 11.2.3. Others
- 11.3. Market Value Forecast, by Application, 2017-2031
- 11.3.1. Production of Semisynthetic Penicillin
- 11.3.2. Production of Semisynthetic Cephalosporin
- 11.3.3. Others
- 11.4. Market Value Forecast, by End-user, 2017-2031
- 11.4.1. Pharmaceutical Companies
- 11.4.2. Academic & Research Institutes
- 11.4.3. Others
- 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.5.1. Germany
- 11.5.2. U.K
- 11.5.3. France
- 11.5.4. Italy
- 11.5.5. Spain
- 11.5.6. Rest of Europe
- 11.6. Market Attractiveness Analysis
- 11.6.1. By Source
- 11.6.2. By Application
- 11.6.3. By End-user
- 11.6.4. By Country/Sub-region
12. Asia Pacific Penicillin G Acylase Market Analysis and Forecast
- 12.1. Introduction
- 12.1.1. Key Findings
- 12.2. Market Value Forecast, by Source, 2017-2031
- 12.2.1. E. coli
- 12.2.2. Bacillus Megaterium
- 12.2.3. Others
- 12.3. Market Value Forecast, by Application, 2017-2031
- 12.3.1. Production of Semisynthetic Penicillin
- 12.3.2. Production of Semisynthetic Cephalosporin
- 12.3.3. Others
- 12.4. Market Value Forecast, by End-user, 2017-2031
- 12.4.1. Pharmaceutical Companies
- 12.4.2. Academic & Research Institutes
- 12.4.3. Others
- 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
- 12.6. Market Attractiveness Analysis
- 12.6.1. By Source
- 12.6.2. By Application
- 12.6.3. By End-user
- 12.6.4. By Country/Sub-region
13. Latin America Penicillin G Acylase Market Analysis and Forecast
- 13.1. Introduction
- 13.1.1. Key Findings
- 13.2. Market Value Forecast, by Source, 2017-2031
- 13.2.1. E. coli
- 13.2.2. Bacillus Megaterium
- 13.2.3. Others
- 13.3. Market Value Forecast, by Application, 2017-2031
- 13.3.1. Production of Semisynthetic Penicillin
- 13.3.2. Production of Semisynthetic Cephalosporin
- 13.3.3. Others
- 13.4. Market Value Forecast, by End-user, 2017-2031
- 13.4.1. Pharmaceutical Companies
- 13.4.2. Academic & Research Institutes
- 13.4.3. Others
- 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
- 13.6. Market Attractiveness Analysis
- 13.6.1. By Source
- 13.6.2. By Application
- 13.6.3. By End-user
- 13.6.4. By Country/Sub-region
14. Middle East & Africa Penicillin G Acylase Market Analysis and Forecast
- 14.1. Introduction
- 14.1.1. Key Findings
- 14.2. Market Value Forecast, by Source, 2017-2031
- 14.2.1. E. coli
- 14.2.2. Bacillus Megaterium
- 14.2.3. Others
- 14.3. Market Value Forecast, by Application, 2017-2031
- 14.3.1. Production of Semisynthetic Penicillin
- 14.3.2. Production of Semisynthetic Cephalosporin
- 14.3.3. Others
- 14.4. Market Value Forecast, by End-user, 2017-2031
- 14.4.1. Pharmaceutical Companies
- 14.4.2. Academic & Research Institutes
- 14.4.3. Others
- 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & South Africa
- 14.6. Market Attractiveness Analysis
- 14.6.1. By Source
- 14.6.2. By Application
- 14.6.3. By End-user
- 14.6.4. By Country/Sub-region
15. Competition Landscape
- 15.1. Market Player - Competition Matrix (by tier and size of companies)
- 15.2. Company Profiles
- 15.2.1. Merck KGaA (Sigma Aldrich)
- 15.2.1.1. Company Overview
- 15.2.1.2. Financial Overview
- 15.2.1.3. Product Portfolio
- 15.2.1.4. Business Strategies
- 15.2.1.5. Recent Developments
- 15.2.2. Fermenta Biotech Ltd.
- 15.2.2.1. Company Overview
- 15.2.2.2. Financial Overview
- 15.2.2.3. Product Portfolio
- 15.2.2.4. Business Strategies
- 15.2.2.5. Recent Developments
- 15.2.3. Biosynth
- 15.2.3.1. Company Overview
- 15.2.3.2. Financial Overview
- 15.2.3.3. Product Portfolio
- 15.2.3.4. Business Strategies
- 15.2.3.5. Recent Developments
- 15.2.4. Amicogen
- 15.2.4.1. Company Overview
- 15.2.4.2. Financial Overview
- 15.2.4.3. Product Portfolio
- 15.2.4.4. Business Strategies
- 15.2.4.5. Recent Developments
- 15.2.5. Creative Enzymes
- 15.2.5.1. Company Overview
- 15.2.5.2. Financial Overview
- 15.2.5.3. Product Portfolio
- 15.2.5.4. Business Strategies
- 15.2.5.5. Recent Developments
- 15.2.6. Crawford Wisdom International
- 15.2.6.1. Company Overview
- 15.2.6.2. Financial Overview
- 15.2.6.3. Product Portfolio
- 15.2.6.4. Business Strategies
- 15.2.6.5. Recent Developments
- 15.2.7. MuseChem Chemicals
- 15.2.7.1. Company Overview
- 15.2.7.2. Financial Overview
- 15.2.7.3. Product Portfolio
- 15.2.7.4. Business Strategies
- 15.2.7.5. Recent Developments
- 15.2.1. Merck KGaA (Sigma Aldrich)
